Which has preferable earnings & valuation, NVST or ALGN?

Align Technology has higher revenue and earnings than Envista. Align Technology is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envista $2.72B 1.60 $47M $0.41 65.18 Align Technology $4.03B 3.14 $410.35M $5.96 29.66

Does the media favor NVST or ALGN?

In the previous week, Align Technology had 4 more articles in the media than Envista. MarketBeat recorded 5 mentions for Align Technology and 1 mentions for Envista. Align Technology's average media sentiment score of 1.10 beat Envista's score of 0.90 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to NVST or XRAY?

In the previous week, DENTSPLY SIRONA had 2 more articles in the media than Envista. MarketBeat recorded 3 mentions for DENTSPLY SIRONA and 1 mentions for Envista. DENTSPLY SIRONA's average media sentiment score of 1.25 beat Envista's score of 0.90 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DENTSPLY SIRONA 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is NVST or BRBR more profitable?

BellRing Brands has a net margin of 6.78% compared to Envista's net margin of 2.41%. Envista's return on equity of 7.11% beat BellRing Brands' return on equity. Company Net Margins Return on Equity Return on Assets Envista 2.41% 7.11% 3.91% BellRing Brands 6.78% -44.06% 19.42%

Does the media refer more to NVST or BRBR?

In the previous week, BellRing Brands had 5 more articles in the media than Envista. MarketBeat recorded 6 mentions for BellRing Brands and 1 mentions for Envista. Envista's average media sentiment score of 0.90 beat BellRing Brands' score of 0.40 indicating that Envista is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BellRing Brands 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, NVST or ZBH?

Zimmer Biomet has higher revenue and earnings than Envista. Zimmer Biomet is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envista $2.72B 1.60 $47M $0.41 65.18 Zimmer Biomet $8.41B 2.10 $705.20M $3.85 23.68

Is NVST or ZBH more profitable?

Zimmer Biomet has a net margin of 9.05% compared to Envista's net margin of 2.41%. Zimmer Biomet's return on equity of 13.24% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets Envista 2.41% 7.11% 3.91% Zimmer Biomet 9.05% 13.24% 7.28%

Does the media refer more to NVST or ZBH?

In the previous week, Zimmer Biomet had 9 more articles in the media than Envista. MarketBeat recorded 10 mentions for Zimmer Biomet and 1 mentions for Envista. Zimmer Biomet's average media sentiment score of 0.91 beat Envista's score of 0.90 indicating that Zimmer Biomet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zimmer Biomet 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, NVST or SOLV?

Solventum has higher revenue and earnings than Envista. Solventum is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envista $2.72B 1.60 $47M $0.41 65.18 Solventum $8.33B 1.69 $1.56B $8.16 9.97

Is NVST or SOLV more profitable?

Solventum has a net margin of 17.33% compared to Envista's net margin of 2.41%. Solventum's return on equity of 23.51% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets Envista 2.41% 7.11% 3.91% Solventum 17.33% 23.51% 7.63%

Does the media refer more to NVST or SOLV?

In the previous week, Solventum had 5 more articles in the media than Envista. MarketBeat recorded 6 mentions for Solventum and 1 mentions for Envista. Solventum's average media sentiment score of 0.99 beat Envista's score of 0.90 indicating that Solventum is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Envista (NVST) Competitors

$26.72 -0.27 (-0.98%)

Closing price 07/17/2026 03:59 PM Eastern

Extended Trading

$26.74 +0.01 (+0.06%)

As of 07/17/2026 04:10 PM Eastern

Compare

NVST vs. ALGN, XRAY, BRBR, ZBH, and SOLV

Should you buy Envista stock or one of its competitors? MarketBeat compares Envista with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Envista include Align Technology (ALGN), DENTSPLY SIRONA (XRAY), BellRing Brands (BRBR), Zimmer Biomet (ZBH), and Solventum (SOLV).

How does Envista compare to Align Technology?

Envista (NYSE:NVST) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability.

In the previous week, Align Technology had 4 more articles in the media than Envista. MarketBeat recorded 5 mentions for Align Technology and 1 mentions for Envista. Align Technology's average media sentiment score of 1.10 beat Envista's score of 0.90 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Envista has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, indicating that its share price is 67% more volatile than the broader market.

Align Technology has a net margin of 10.50% compared to Envista's net margin of 2.41%. Align Technology's return on equity of 15.82% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
Align Technology	10.50%	15.82%	10.17%

88.4% of Align Technology shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Envista currently has a consensus price target of $28.54, indicating a potential upside of 6.79%. Align Technology has a consensus price target of $206.07, indicating a potential upside of 16.58%. Given Align Technology's stronger consensus rating and higher probable upside, analysts clearly believe Align Technology is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

Align Technology has higher revenue and earnings than Envista. Align Technology is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.60	$47M	$0.41	65.18
Align Technology	$4.03B	3.14	$410.35M	$5.96	29.66

Summary

Align Technology beats Envista on 15 of the 17 factors compared between the two stocks.

How does Envista compare to DENTSPLY SIRONA?

Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, DENTSPLY SIRONA had 2 more articles in the media than Envista. MarketBeat recorded 3 mentions for DENTSPLY SIRONA and 1 mentions for Envista. DENTSPLY SIRONA's average media sentiment score of 1.25 beat Envista's score of 0.90 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DENTSPLY SIRONA	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Envista has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market.

Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.60	$47M	$0.41	65.18
DENTSPLY SIRONA	$3.68B	0.77	-$598M	-$3.15	N/A

95.7% of DENTSPLY SIRONA shares are held by institutional investors. 1.0% of Envista shares are held by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Envista has a net margin of 2.41% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

Envista presently has a consensus target price of $28.54, indicating a potential upside of 6.79%. DENTSPLY SIRONA has a consensus target price of $13.42, indicating a potential downside of 4.58%. Given Envista's stronger consensus rating and higher possible upside, research analysts clearly believe Envista is more favorable than DENTSPLY SIRONA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Envista beats DENTSPLY SIRONA on 9 of the 16 factors compared between the two stocks.

How does Envista compare to BellRing Brands?

Envista (NYSE:NVST) and BellRing Brands (NYSE:BRBR) are related companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

BellRing Brands has a net margin of 6.78% compared to Envista's net margin of 2.41%. Envista's return on equity of 7.11% beat BellRing Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
BellRing Brands	6.78%	-44.06%	19.42%

95.0% of BellRing Brands shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 1.5% of BellRing Brands shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Envista has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market. Comparatively, BellRing Brands has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market.

In the previous week, BellRing Brands had 5 more articles in the media than Envista. MarketBeat recorded 6 mentions for BellRing Brands and 1 mentions for Envista. Envista's average media sentiment score of 0.90 beat BellRing Brands' score of 0.40 indicating that Envista is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BellRing Brands	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Envista currently has a consensus price target of $28.54, indicating a potential upside of 6.79%. BellRing Brands has a consensus price target of $20.57, indicating a potential upside of 69.43%. Given BellRing Brands' stronger consensus rating and higher possible upside, analysts plainly believe BellRing Brands is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
BellRing Brands	1 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.47

BellRing Brands has lower revenue, but higher earnings than Envista. BellRing Brands is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.60	$47M	$0.41	65.18
BellRing Brands	$2.32B	0.61	$216.20M	$1.29	9.41

Summary

BellRing Brands beats Envista on 11 of the 17 factors compared between the two stocks.

How does Envista compare to Zimmer Biomet?

Envista (NYSE:NVST) and Zimmer Biomet (NYSE:ZBH) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

88.9% of Zimmer Biomet shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 1.3% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Envista has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Zimmer Biomet has a beta of 0.46, suggesting that its share price is 54% less volatile than the broader market.

Zimmer Biomet has a net margin of 9.05% compared to Envista's net margin of 2.41%. Zimmer Biomet's return on equity of 13.24% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
Zimmer Biomet	9.05%	13.24%	7.28%

Zimmer Biomet has higher revenue and earnings than Envista. Zimmer Biomet is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.60	$47M	$0.41	65.18
Zimmer Biomet	$8.41B	2.10	$705.20M	$3.85	23.68

Envista presently has a consensus target price of $28.54, indicating a potential upside of 6.79%. Zimmer Biomet has a consensus target price of $100.70, indicating a potential upside of 10.44%. Given Zimmer Biomet's higher probable upside, analysts clearly believe Zimmer Biomet is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
Zimmer Biomet	3 Sell rating(s)	13 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.25

In the previous week, Zimmer Biomet had 9 more articles in the media than Envista. MarketBeat recorded 10 mentions for Zimmer Biomet and 1 mentions for Envista. Zimmer Biomet's average media sentiment score of 0.91 beat Envista's score of 0.90 indicating that Zimmer Biomet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zimmer Biomet	4 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Zimmer Biomet beats Envista on 14 of the 17 factors compared between the two stocks.

How does Envista compare to Solventum?

Envista (NYSE:NVST) and Solventum (NYSE:SOLV) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Envista has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market. Comparatively, Solventum has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market.

In the previous week, Solventum had 5 more articles in the media than Envista. MarketBeat recorded 6 mentions for Solventum and 1 mentions for Envista. Solventum's average media sentiment score of 0.99 beat Envista's score of 0.90 indicating that Solventum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Solventum	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Envista currently has a consensus price target of $28.54, indicating a potential upside of 6.79%. Solventum has a consensus price target of $81.91, indicating a potential upside of 0.68%. Given Envista's higher possible upside, analysts clearly believe Envista is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
Solventum	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

Solventum has higher revenue and earnings than Envista. Solventum is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.60	$47M	$0.41	65.18
Solventum	$8.33B	1.69	$1.56B	$8.16	9.97

Solventum has a net margin of 17.33% compared to Envista's net margin of 2.41%. Solventum's return on equity of 23.51% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
Solventum	17.33%	23.51%	7.63%

Summary

Solventum beats Envista on 10 of the 13 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NVST vs. The Competition

Export

Metric	Envista	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$4.39B	$8.81B	$6.87B	$23.46B
Dividend Yield	N/A	2.46%	2.67%	4.15%
P/E Ratio	65.18	16.06	27.23	30.95
Price / Sales	1.60	6.43	529.67	19.25
Price / Cash	12.43	18.35	51.46	32.65
Price / Book	1.41	3.28	10.69	4.76
Net Income	$47M	$228.19M	$3.59B	$1.07B
7 Day Performance	2.98%	-2.43%	-2.20%	-0.01%
1 Month Performance	3.04%	-1.02%	1.63%	1.08%
1 Year Performance	37.33%	0.14%	25.59%	16.61%

Envista Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NVST Envista	2.1447 of 5 stars	$26.73 -1.0%	$28.54 +6.8%	+35.2%	$4.39B	$2.72B	65.18	12,000
ALGN Align Technology	3.7338 of 5 stars	$188.39 +2.1%	$205.85 +9.3%	-8.1%	$13.21B	$4.03B	31.61	20,290	Positive News Analyst Downgrade
XRAY DENTSPLY SIRONA	3.6016 of 5 stars	$12.32 +5.8%	$13.55 +9.9%	-10.9%	$2.33B	$3.68B	N/A	14,000
BRBR BellRing Brands	4.0362 of 5 stars	$13.44 -3.0%	$22.47 +67.2%	-78.8%	$1.61B	$2.32B	10.42	380	News Coverage Analyst Forecast
ZBH Zimmer Biomet	3.439 of 5 stars	$89.75 +2.6%	$102.70 +14.4%	-3.9%	$16.92B	$8.23B	23.31	17,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NVST) was last updated on 7/18/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Envista (NVST) Competitors

NVST vs. ALGN, XRAY, BRBR, ZBH, and SOLV

How does Envista compare to Align Technology?

Summary

How does Envista compare to DENTSPLY SIRONA?

Summary

How does Envista compare to BellRing Brands?

Summary

How does Envista compare to Zimmer Biomet?

Summary

How does Envista compare to Solventum?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVST vs. The Competition

Envista Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Envista (NVST) Competitors

NVST vs. ALGN, XRAY, BRBR, ZBH, and SOLV

How does Envista compare to Align Technology?

Does the media favor NVST or ALGN?

Which has more risk & volatility, NVST or ALGN?

Is NVST or ALGN more profitable?

Do insiders & institutionals have more ownership in NVST or ALGN?

Do analysts rate NVST or ALGN?

Which has preferable earnings & valuation, NVST or ALGN?

Summary

How does Envista compare to DENTSPLY SIRONA?

Does the media refer more to NVST or XRAY?

Which has more volatility & risk, NVST or XRAY?

Which has stronger valuation & earnings, NVST or XRAY?

Do insiders and institutionals have more ownership in NVST or XRAY?

Is NVST or XRAY more profitable?

Do analysts rate NVST or XRAY?

Summary

How does Envista compare to BellRing Brands?

Is NVST or BRBR more profitable?

Do institutionals & insiders have more ownership in NVST or BRBR?

Which has more volatility and risk, NVST or BRBR?

Does the media refer more to NVST or BRBR?

Do analysts rate NVST or BRBR?

Which has better earnings and valuation, NVST or BRBR?

Summary

How does Envista compare to Zimmer Biomet?

Do institutionals and insiders have more ownership in NVST or ZBH?

Which has more risk & volatility, NVST or ZBH?

Is NVST or ZBH more profitable?

Which has higher valuation and earnings, NVST or ZBH?

Do analysts rate NVST or ZBH?

Does the media refer more to NVST or ZBH?

Summary

How does Envista compare to Solventum?

Which has more volatility & risk, NVST or SOLV?

Does the media refer more to NVST or SOLV?

Do analysts prefer NVST or SOLV?

Which has higher earnings and valuation, NVST or SOLV?

Is NVST or SOLV more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVST vs. The Competition

Envista Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools